Showing posts with label adjuvant. Show all posts
Showing posts with label adjuvant. Show all posts
Thursday, December 29, 2011
Tuesday, July 06, 2010
Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer
CONCLUSIONS.: Our study suggests that chemotherapy may be withheld for primary therapy and utilized only for recurrence.
add your opinions
adjuvant
,
chemotherapy
,
immature ovarian teratoma
,
recurrent
,
stage 1
Tuesday, May 18, 2010
Tuesday, April 27, 2010
abstract: Tumor Type and Substage Predict Survival in Stage I and II Ovarian Carcinoma: Insights and Implications
"Tumor grade has been the most accepted prognostic indicator of disease-specific survival among women with stage I and II ovarian carcinomas. Many investigators have included stage IB, grade 1 at diagnosis as low-risk disease and have suggested that women in this category should not receive adjuvant therapy. However, grading assignment appears to be unreliable because of problems with reproducibility and lack of consideration of biological differences between the different tumor types. Some investigators believe that classification based on tumor typing using new histopathological criteria was more reproducible than grade assignment and would more accurately reflect biological differences..."cont'd
add your opinions
adjuvant
,
cell types
,
early stage
,
first line therapy
,
grade
,
low risk
Saturday, January 23, 2010
Jan 23, 2009: Commentary (1 of 2): Dose-dense paclitaxel for advanced ovarian cancer : The Lancet
Note: may require registration (free):
Subscribe to:
Posts
(
Atom
)